Study of Irinotecan,Oxaliplatin, and S1 in Patients With Advanced Pancreatic Cancer

Summary

To identify the efficiency of Irinotecan, Oxaliplatin, and S1 in patients with previously untreated local regional or metastatic pancreatic cancer.

Timeline

Start

2018-01-26

Primary completion

2022-12-31

Completion

2023-02-28

Publications

• Nie K, Zhang L, You Y, Li H, Guo X, Zhang Z, Zhang C, Ji Y. Irinotecan combined with oxaliplatin and S-1 in patients with metastatic pancreatic adenocarcinoma: a single-arm, three-centre, prospective study. Ther Adv Med Oncol. 2020 Nov 12;12:1758835920970843. doi: 10.1177/1758835920970843. eCollection 2020.

Drugs

Indications

No indication recorded.